Kenichi Harada
Overview
Explore the profile of Kenichi Harada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
435
Citations
5292
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sebe M, Senoura S, Miura K, Kobayashi W, Yano N, Yamauchi G, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076415
Periodontitis is one of the most common diseases associated with the lifestyle habits of adults and is caused by the formation of biofilms, called dental plaques, in periodontal pockets by...
2.
Terashima T, Harada K, Yamashita T
Jpn J Clin Oncol
. 2025 Feb;
PMID: 39936601
The concept and definition of combined hepatocellular-cholangiocarcinoma (cHCC-CCA), an extremely rare condition accounting for only 1% of all primary liver cancers, has shifted in recent years. The latest World Health...
3.
Nakade Y, Iwata Y, Harada K, Sato Y, Mita M, Hamase K, et al.
Amino Acids
. 2024 Dec;
57(1):4.
PMID: 39718666
The relationship between D-AA metabolic enzymes and cancer development remains unclear. We aimed to investigate this relationship using mice deficient in D-AA-related metabolic enzymes. We examined mice lacking these enzymes...
4.
Nakanuma Y, Li Z, Sato Y, Sasaki M, Harada K, Kakuda Y, et al.
Cancers (Basel)
. 2024 Nov;
16(22).
PMID: 39594825
There are several types of microvasculature supplying neoplasms: "newly formed blood vessels" (neoangiogenesis), which are a component of the tumor microenvironment (TME) of invasive carcinoma with wound healing-like reaction; and...
5.
Minato A, Tomisaki I, Kimuro R, Higashijima K, Harada M, Jojima K, et al.
Nihon Hinyokika Gakkai Zasshi
. 2024 Oct;
114(4):99-107.
PMID: 39428549
(Objective) The study aimed to retrospectively evaluate the therapeutic effects of adjuvant chemotherapy (AC) in patients following radical cystectomy (RC) in locally advanced bladder cancer. (Methods) A single-center-derived database registered...
6.
Nagata Y, Minato A, Aono H, Kimuro R, Higashijima K, Tomisaki I, et al.
Int J Mol Sci
. 2024 Oct;
25(19).
PMID: 39408678
Locally advanced or metastatic urothelial carcinoma is a genomically and molecularly heterogeneous disease associated with various clinical outcomes. We aimed to evaluate the association between the status of p53/FGFR3 expression...
7.
Komori T, Yoneda N, Kozaka K, Ohno N, Takata N, Seki A, et al.
Abdom Radiol (NY)
. 2024 Oct;
PMID: 39395043
No abstract available.
8.
Nguyen Q, Nguyen H, Takahashi K, Yoshimura K, Ikeda H, Kozaka K, et al.
Med Mol Morphol
. 2024 Oct;
58(1):75-82.
PMID: 39375230
Adenosquamous carcinoma (ASC) with the presence of a sarcomatous component is exceptionally uncommon in intrahepatic cholangiocarcinoma (iCCA). We report a case of hepatic ASC with rhabdoid transformation, one variation of...
9.
Fujimoto N, Nagata Y, Shiota M, Minato A, Tomisaki I, Harada K, et al.
In Vivo
. 2024 Aug;
38(5):2328-2334.
PMID: 39187338
Background/aim: In patients with metastatic castration-sensitive prostate cancer (mCSPC), upfront treatment intensification with the addition of new hormonal agents and/or docetaxel to androgen deprivation therapy (ADT) is recommended. However, this...
10.
Kakisaka K, Nakayama N, Kumagai K, Hisanaga T, Kondo T, Setsu T, et al.
Gastro Hep Adv
. 2024 Aug;
2(4):497-504.
PMID: 39132042
Background And Aims: Acute liver injury (ALI) due to autoimmune hepatitis (AIH) can be treated by immunosuppression. In contrast, idiosyncratic drug-induced liver injury (DILI) had a poor prognosis. DILI thus...